How can LVAD support influence ventricular energetics parameters in advanced heart failure patients? A retrospective study

被引:1
|
作者
De Lazzari, Claudio [1 ,2 ]
Capoccia, Massimo [3 ,4 ]
Marconi, Silvia [1 ]
机构
[1] Inst Clin Physiol IFC CNR, Natl Res Council, Via Palestro, I-00185 Rome, Italy
[2] Natl Inst Cardiovasc Res INRC, Via Irnerio 48, I-40126 Bologna, Italy
[3] Royal Brompton Harefield NHS Fdn Trust, Royal Brompton Hosp, London, England
[4] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland
关键词
Heart failure; External work; Pressure volume area; Software simulation; LVAD; Milrinone; MECHANICAL VENTILATION; EJECTION FRACTION; ASSIST; DEVICE; PRESSURE; SIMULATION; MODEL; RATIO; PUMP;
D O I
10.1016/j.cmpb.2019.02.012
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Background and objective: Here we present a retrospective analysis of six heart failure patients previously discussed at a multidisciplinary team meeting. Only three out of six patients underwent LVAD insertion as the most appropriate management option. Methods: We sought to reproduce the baseline conditions of these patients on hospital admission using our cardiovascular software simulator (CARDIOSIM (c)). Subsequently, we simulated the effects of LVAD support and drug administration on left and right ventricular energetics parameters. LVAD assistance was delivered by CARDIOSIM (c) based on the module reproducing the behaviour of the Berlin Heart INCOR pump. Results: The results of our simulations were in agreement with the multidisciplinary team meeting outcome. The analysis of ventricular energetics parameters based on external work and pressure volume area confirmed LVAD support as a beneficial therapeutic option for the three patients considered eligible for this type of treatment. The effects induced by LVAD support and drugs administration showed specific patterns between the two groups of patients. Conclusion: A quantitative approach with the ability to predict outcome during patient's assessment may well be an aid and not a substitute for clinical decision-making. (C) 2019 Published by Elsevier B.V.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 50 条
  • [11] Diminished left ventricular contractility overtime during LVAD support in ischemic heart failure
    McConnell, P. I.
    Del Rio, C. L.
    Kwiatkowski, P.
    Farrar, D. J.
    Sun, B. C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S93 - S93
  • [12] Rivaroxaban in heart failure patients with left ventricular thrombus: A retrospective study
    Zhang, Qian
    Zhang, Zhongfan
    Zheng, Haikuo
    Qu, Ming
    Li, Shouping
    Yang, Ping
    Si, Daoyuan
    Zhang, Wenqi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [13] Outcomes of COVID-19 in heart failure, LVAD, and heart transplant patients in an advanced heart failure practice
    George, Susan
    Cunningham, Luke C.
    Nelson, David P.
    Horstmanshof, Douglas A.
    Long, James W.
    El Banayosy, Ahmed M.
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 24
  • [14] Which "Roadmap" in Patients With Advanced or Refractory Heart Failure, Eligible for LVAD and Heart Transplantation?
    Bertoldi, L. F.
    Perna, E.
    Giglio, A. F.
    Ammirati, E.
    Cipriani, M. G.
    Garascia, A.
    Macera, F.
    D'Angelo, L.
    Varrenti, M.
    Costetti, A.
    Nonini, S.
    Gagliardone, M. P.
    Russo, C.
    Camici, P. G.
    Frigerio, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S311 - S311
  • [15] Long Term Support of Patients Receiving an LVAD for Advanced Heart Failure: A Subgroup Analysis of the Registry to Evaluate the HeartWare® Left Ventricular Assist System (The REVOLVE Registry)
    Schmitto, J. D.
    Zimpfer, D.
    Fiane, A. E.
    Larbalestier, R.
    Tsui, S.
    Jansz, P.
    Simon, A.
    Schueler, S.
    Strueber, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S9 - S9
  • [16] Assessment of Frailty in Patients With Advanced Heart Failure Before and After LVAD Implantation
    Heaney, Cassandra
    Vuthoori, Ravi K.
    Gibson, Gregory
    Miller, Edmund
    Fernandez, Harold
    Lima, Brian
    Taylor, James
    Davidson, Kathleen
    Kennedy, Kevin F.
    Majure, David T.
    Stevens, Gerin R.
    Maybaum, Simon
    CIRCULATION, 2019, 140
  • [17] Advanced Heart Failure ARIES-HM3 Study: Aspirin Therapy not necessary in Patients with LVAD
    Fisch, S.
    JOURNAL FUR KARDIOLOGIE, 2024, 31 (11-12):
  • [18] Ventricular Assist Devices in Heart Failure: How to Support the Heart but Prevent Atrophy?
    Pokorny, M.
    Cervenka, L.
    Netuka, I.
    Pirk, J.
    Konarik, M.
    Maly, J.
    PHYSIOLOGICAL RESEARCH, 2014, 63 (02) : 147 - 156
  • [19] Clinical and echocardiographic effects of vericiguat therapy in advanced heart failure patinets undergoing LVAD support
    Poglajen, G.
    Frljak, S.
    Zemljic, G.
    Cerar, A.
    Knezevic, I.
    Vrtovec, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 284 - 284
  • [20] Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure
    Santangeli, Pasquale
    Rame, J. Eduardo
    Birati, Edo Y.
    Marchlinski, Francis E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (14) : 1842 - 1860